These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice. Hosogi M; Tonogaito H; Aioi A; Hamada K; Shimoda K; Muromoto R; Matsuda T; Miyachi Y J Dermatol Sci; 2004 Oct; 36(1):51-6. PubMed ID: 15488705 [TBL] [Abstract][Full Text] [Related]
7. Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formation. Shimoda K; Kamesaki K; Numata A; Aoki K; Matsuda T; Oritani K; Tamiya S; Kato K; Takase K; Imamura R; Yamamoto T; Miyamoto T; Nagafuji K; Gondo H; Nagafuchi S; Nakayama K; Harada M J Immunol; 2002 Nov; 169(9):4707-11. PubMed ID: 12391177 [TBL] [Abstract][Full Text] [Related]
8. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner. Krishnan K; Pine R; Krolewski JJ Eur J Biochem; 1997 Jul; 247(1):298-305. PubMed ID: 9249040 [TBL] [Abstract][Full Text] [Related]
9. Tyk2-signaling plays an important role in host defense against Escherichia coli through IL-23-induced IL-17 production by gammadelta T cells. Nakamura R; Shibata K; Yamada H; Shimoda K; Nakayama K; Yoshikai Y J Immunol; 2008 Aug; 181(3):2071-5. PubMed ID: 18641345 [TBL] [Abstract][Full Text] [Related]
11. Control of Leishmania major in the absence of Tyk2 kinase. Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057 [TBL] [Abstract][Full Text] [Related]
12. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18. Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. Franchimont D; Galon J; Gadina M; Visconti R; Zhou Y; Aringer M; Frucht DM; Chrousos GP; O'Shea JJ J Immunol; 2000 Feb; 164(4):1768-74. PubMed ID: 10657623 [TBL] [Abstract][Full Text] [Related]
14. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice. Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517 [TBL] [Abstract][Full Text] [Related]
16. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. Bright JJ; Sriram S J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043 [TBL] [Abstract][Full Text] [Related]
17. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation. Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069 [TBL] [Abstract][Full Text] [Related]
18. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853 [TBL] [Abstract][Full Text] [Related]
19. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent. Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498 [TBL] [Abstract][Full Text] [Related]